Amolyt Pharma
19 known investors
Find your way into Amolyt Pharma
Sign up to see every warm intro you have to Amolyt Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Amolyt Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Developing therapeutic peptides targeting rare endocrine diseases (past investment).
Investors · 19
How we know: Andera Partners's portfolio page · a partner's Signal profile · sofinnovapartners.com · globenewswire.com · Not right? Tell us
How we know: ATEM Capital Fund's portfolio page · globenewswire.com · Not right? Tell us
How we know: CTI Life Sciences Fund L.P.'s portfolio page · Not right? Tell us
How we know: EQT Life Sciences's portfolio page · a partner's Signal profile · sofinnovapartners.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Kurma Partners's portfolio page · a partner's Signal profile · sofinnovapartners.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Octalfa's portfolio page · Not right? Tell us
How we know: Sofinnova Partners's portfolio page · sofinnovapartners.com · open dataset · 5k.vc investor directory · Not right? Tell us
Also in the syndicate · 8
Funding
SEC filings, press & company announcements- Undisclosed amountSeries CJan 2023
Intermediate Capital Group (lead), Sofinnova Partners (lead), Andera Partners, ATEM, Credit Agricole Creation, CTI Life Sciences, EQT Life Sciences, Innobio 2 managed by Bpifrance Investissement, Kurma Partners, Mass General Brigham Ventures, Novo Holdings (Novo Ventures), Orbimed, Pontifax, Relyens Innovation Santé/Turenne Capital, Sectoral Asset Management, Tekla Capital Investment LLC
Source ↗ - Undisclosed amountSeries BSep 2021
Andera Partners (lead), Sectoral Asset Management (lead), ATEM Capital, LSP
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Amolyt Pharma do?
- Developing therapeutic peptides targeting rare endocrine diseases (past investment).
- Who are Amolyt Pharma's investors?
- Amolyt Pharma's investors include Andera Partners, ATEM Capital Fund, CTI Life Sciences Fund L.P., EQT Life Sciences, Kurma Partners, Octalfa, Sofinnova Partners, Intermediate Capital Group and 3 more.






